Atlas Trials

Nivolumab and Dasatinib in Treating Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Clinical trial NCT02819804 · TERMINATED

Trial details

NCT number
NCT02819804
Sponsor
Northwestern University
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1Recurrent Adult Acute Lymphoblastic LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRefractory Adult Acute Lymphoblastic LeukemiaRefractory Childhood Acute Lymphoblastic Leukemia
Start date
2017-08-17
Primary completion
2017-08-27
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.